2004
DOI: 10.1016/j.bmcl.2003.11.084
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis, topoisomerase I inhibition and structure–activity relationship study of 2,4,6-trisubstituted pyridine derivatives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
24
0

Year Published

2004
2004
2018
2018

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 90 publications
(24 citation statements)
references
References 20 publications
0
24
0
Order By: Relevance
“…Further experiments investigated the fluorescence of NQD in the presence of CTP. Diaryl-substituted pyridine derivatives are bioisosteres of terpyridine that are known to exhibit a strong cytotoxicity against several human cancer cell lines through the inhibition of topoisomerase I [44][45][46][47][48]. An analog of such diaryl-substituted pyridines (CTP) was synthesized using 3-dimethylamino-1-(thiophen-2-yl)-1-propanone hydrochloride 1 (a ke- tonic Mannich base), 4-chlorophenacylpyridinium bromide 2 and ammonium acetate as starting materials in an one-pot approach (Figure 8).…”
Section: Results and Discussion 41 Morphologies And Structuresmentioning
confidence: 99%
“…Further experiments investigated the fluorescence of NQD in the presence of CTP. Diaryl-substituted pyridine derivatives are bioisosteres of terpyridine that are known to exhibit a strong cytotoxicity against several human cancer cell lines through the inhibition of topoisomerase I [44][45][46][47][48]. An analog of such diaryl-substituted pyridines (CTP) was synthesized using 3-dimethylamino-1-(thiophen-2-yl)-1-propanone hydrochloride 1 (a ke- tonic Mannich base), 4-chlorophenacylpyridinium bromide 2 and ammonium acetate as starting materials in an one-pot approach (Figure 8).…”
Section: Results and Discussion 41 Morphologies And Structuresmentioning
confidence: 99%
“…37 It is interesting to note that the above procedure, when carefully adjusted, gave access to pyridine ring systems with variously substituted aryl substituents. The same group demonstrated the high activity of a catalytic system consisting of Pd 2 (dba) 3 and di(1-adamantyl)-n-butylphosphine as ligand for Suzuki cross coupling of tetrachloropyridine with a wide variety of arylboronic acids. 38 Also in this case, careful optimization of reaction conditions led to the regioselective step-wise arylation of the pyridine ring system.…”
Section: Resultsmentioning
confidence: 99%
“…Application of the classical Suzuki catalytic system based on Pd[PPh 3 ] and PdCl 2 [PPh 3 ] 2 in the presence of a medium-strong (Na 2 CO 3 ) or a weak base (K 3 PO 4 ) brought about the formation of 2a in low yield (entries 1-3). The GC-MS analysis indicated significant amounts of chloropyridine 7 and by-products A-C. Interestingly, when more bulky ligand P(o-tol) 3 was used instead of PPh 3 , the arylation occurred predominantly at 3 and 5 positions of 9 leading selectively to compound 7 in 92% yield (entry 4). Similar results were obtained when Pd(dppf)Cl 2 ×CH 2 Cl 2 (4) and a catalytic system consisting of Pd(OAc) 2 / tricyclohexylphosphine was used in the presence of a weak base K 3 PO 4 (entries 9 and 6, respectively).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Some pyridine derivatives were studied for their topoisomerase inhibitory activity and cytotoxicity against several human cancer cell lines for the development of novel anticancer agents. As a result, it has been reported that various pyridine derivatives, as bioisosteres of α-terthiophene (potent protein kinase C inhibitor) [23], have significant topoisomerase I and/or II inhibitory activity, and cytotoxicity against several human cancer cell lines [24][25][26][27][28]. Early reports on the ability of α-terpyridine to form metal complexes [29] and to and to bind with DNA/RNA [30] have been the base for the study on pyridine derivatives as antitumor agents.…”
Section: Introductionmentioning
confidence: 99%